Pneumococcal 15-valent conjugate vaccine
Generic name: Pneumococcal 15-valent Conjugate Vaccine
Brand names: Vaxneuvance
Dosage form: intramuscular suspension (-)
Drug class:
Bacterial vaccines
Usage of Pneumococcal 15-valent conjugate vaccine
Pneumococcal disease is a serious infection caused by a bacteria that can infect the sinuses, inner ear, lungs, blood, and brain. These conditions can be fatal.
Pneumococcal 15-valent conjugate vaccine is used in adults to help prevent disease caused by pneumococcal bacteria. This vaccine contains 15 different types of pneumococcal bacteria.
This vaccine helps your body develop immunity to the disease, but will not treat an active infection you already have.
Like any vaccine, pneumococcal 15-valent conjugate vaccine may not provide protection from disease in every person.
Pneumococcal 15-valent conjugate vaccine side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Keep track of all side effects you have. If you ever need another pneumococcal 15-valent conjugate vaccine, you will need to tell the vaccination provider if the previous shot caused any side effects.
Becoming infected with pneumococcal disease is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is low.
Common side effects of pneumococcal 15-valent conjugate vaccine may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.
Before taking Pneumococcal 15-valent conjugate vaccine
You should not receive this vaccine if you ever had a severe allergic reaction to a pneumococcal or diphtheria toxoid vaccine.
Tell the vaccination provider if you have:
You can still receive a vaccine if you have a minor cold. In the case of a more severe illness with a fever or any type of infection, wait until you get better before receiving this vaccine.
Tell the vaccination provider if you are pregnant or breastfeeding.
Relate drugs
- ActHIB
- Anthrax vaccine
- Anthrax vaccine adsorbed, adjuvanted
- Cyfendus
- BCG vaccine
- Bexsero
- Bexsero (MenB)
- BioThrax
- Cholera vaccine
- Haemophilus b conjugate (PRP-OMP) vaccine
- Haemophilus b conjugate (PRP-T) vaccine
- Haemophilus b conjugate vaccine
- Hiberix
- Hibtiter
- Liquid PedvaxHIB
- Lyme disease vaccine (recombinant ospa)
- Menactra
- Menactra (Meningococcal polysaccharide vaccine, diphtheria conjugate Intramuscular)
- MenHibrix
- Meningococcal conjugate vaccine
- Meningococcal group B vaccine
- Meningococcal polysaccharide vaccine, diphtheria conjugate
- Meningococcal vaccine and haemophilus b vaccine
- Meningococcal vaccine, diphtheria conjugate
- Meningococcal vaccine, tetanus toxoid conjugate quadrivalent
- Menveo
- Pedvaxhib
- Pneumococcal 13-valent conjugate vaccine
- Pneumococcal 13-valent vaccine, diphtheria conjugate
- Pneumococcal 15-valent conjugate vaccine
- Pneumococcal 20-valent conjugate vaccine
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pneumovax 23
- Prevnar 13
- Prevnar 20
- TE Anatoxal Berna
- Tetanus toxoid
- Trumenba
- Typhim VI
- Typhoid vaccine (inactivated), injection
- Typhoid vaccine (live), oral
- Typhoid vaccine, inactivated
- Typhoid vaccine, live
- Vaxchora
- Vaxneuvance
- Vivotif
- Vivotif Berna
How to use Pneumococcal 15-valent conjugate vaccine
Usual Adult Dose for Pneumococcal Disease Prophylaxis:
0.5 mL IM onceUse: Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33
Usual Pediatric Dose for Pneumococcal Disease Prophylaxis:
0.5 mL IM as a 4 dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the third dose)0.5 mL IM as a 3 dose series at 7 through 11 months of age (the first 2 doses are given at least 4 weeks apart; third dose given after the one-year birthday, separated from the second dose by at least 2 months)0.5 mL IM as a 2 dose series at 12 through 23 months of age (two doses at least 2 months apart)0.5 mL IM once to 2 through 17 years of age (and at least 2 months after the third dose)Comments: -The first dose can be initiated at as early as 6 weeks of age.-The 4-dose series started with a lower valency pneumococcal conjugate vaccine can be completed with this vaccine. -Children and adolescents 2 years through 17 years of age who have received an incomplete series of another pneumococcal conjugate vaccine can be administered this vaccine in a single dose with a gap of at least 2 months from the last dose of another pneumococcal conjugate vaccine.Use: Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
Warnings
You should not receive this vaccine if you ever had a severe allergic reaction to a pneumococcal or diphtheria toxoid vaccine.
What other drugs will affect Pneumococcal 15-valent conjugate vaccine
Tell the vaccination provider if you have recently received drugs or treatments that can weaken the immune system, including:
This list is not complete. Other drugs may affect pneumococcal 15-valent conjugate vaccine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions